Healthcare provider profile · identity verified

Heather H Sena, MD

Internal Medicine · COLORADO SPRINGS, CO · NPI 1598870131

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	470	127
Atorvastatin Calcium	Atorvastatin Calcium	416	119
Rosuvastatin Calcium	Rosuvastatin Calcium	360	108
Alendronate Sodium	Alendronate Sodium	318	91
Losartan Potassium	Losartan Potassium	273	76
Amlodipine Besylate	Amlodipine Besylate	202	61
Omeprazole	Omeprazole	198	61
Lisinopril	Lisinopril	193	59
Gabapentin	Gabapentin	192	66
Trazodone Hcl	Trazodone Hcl	112	41
Metoprolol Succinate	Metoprolol Succinate	108	33
Sertraline Hcl	Sertraline Hcl	105	29
Montelukast Sodium	Montelukast Sodium	102	35
Simvastatin	Simvastatin	99	27
Fluticasone Propionate	Fluticasone Propionate	96	46
Hydrochlorothiazide	Hydrochlorothiazide	94	32
Metformin Hcl	Metformin Hcl	91	29
Escitalopram Oxalate	Escitalopram Oxalate	88	30
Duloxetine Hcl	Duloxetine Hcl	80	30
Fluoxetine Hcl	Fluoxetine Hcl	78	19
Jardiance	Empagliflozin	78	25
Famotidine	Famotidine	74	26
Mounjaro	Tirzepatide	67	14
Ozempic	Semaglutide	67	11
Furosemide	Furosemide	65	24
Albuterol Sulfate Hfa	Albuterol Sulfate	62	33
Eliquis	Apixaban	60	20
Meloxicam	Meloxicam	58	24
Allopurinol	Allopurinol	57	17
Pantoprazole Sodium	Pantoprazole Sodium	52	20
Synthroid	Levothyroxine Sodium	51	13
Pravastatin Sodium	Pravastatin Sodium	50	14
Potassium Chloride	Potassium Chloride	49	22
Celecoxib	Celecoxib	48	17
Metoprolol Tartrate	Metoprolol Tartrate	48	14
Spironolactone	Spironolactone	47	15
Buspirone Hcl	Buspirone Hcl	46	15
Tramadol Hcl	Tramadol Hcl	46	16
Zolpidem Tartrate	Zolpidem Tartrate	44	16
Estradiol	Estradiol	42	20
Bupropion Xl	Bupropion Hcl	40	13
Glipizide	Glipizide	40	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	40	13
Lorazepam	Lorazepam	39	suppressed
Pregabalin	Pregabalin	37	suppressed
Symbicort	Budesonide/Formoterol Fumarate	36	12
Valacyclovir	Valacyclovir Hcl	36	20
Acyclovir	Acyclovir	35	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	11
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Clonidine Hcl	Clonidine Hcl	34	11
Donepezil Hcl	Donepezil Hcl	33	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	11
Metformin Hcl Er	Metformin Hcl	31	suppressed
Clonazepam	Clonazepam	30	suppressed
Memantine Hcl	Memantine Hcl	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	18
Ezetimibe	Ezetimibe	28	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	28	13
Atenolol	Atenolol	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	13
Mirtazapine	Mirtazapine	26	12
Alprazolam	Alprazolam	25	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	11
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Glyburide	Glyburide	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	suppressed
Carvedilol	Carvedilol	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	13
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Promethazine Hcl	Promethazine Hcl	20	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Fluconazole	Fluconazole	19	11
Glipizide Er	Glipizide	19	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Valsartan	Valsartan	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Mometasone Furoate	Mometasone Furoate	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	16
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Topiramate	Topiramate	16	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Nystatin	Nystatin	15	12
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Diazepam	Diazepam	13	suppressed
Finasteride	Finasteride	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Primidone	Primidone	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Victoza 3-Pak	Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error